NexGard Spectra Spot-On for Cats is a breakthrough all-in-one parasite prevention treatment for cats. This highly efficacious monthly topical treatment kills external parasites like fleas, paralysis ticks, bush ticks, brown dog ticks, notoedric mange, and ear mites, as well as internal parasites like heart worm larvae, roundworms, hookworms, lungworms, and tapeworms, including flea tapeworms and cat tapeworms. It also helps control flea allergy dermatitis in cats.
This next-generation, easy-to-use, monthly cat parasite prevention treatment contains esafoxolaner, eprinomectin, and praziquantel. Its triple-action formula offers broad-spectrum protection for your cat and eliminates the need to use multiple parasite protection treatments. NexGard Spectra Spot-On Treatment for Cats is suitable for cats and kittens up to 8 weeks of age weighing more than 0.8 kg, as well as for pregnant, breeding, and lactating queens.
Protect your beloved cat from dangerous parasites with just one easy spot-on application of the most complete parasite protection – NexGard Spectra for Cats!
Protection from fleas & ticks - NexGard Spectra for Cats offers effective flea protection for at least 5 weeks. It also protects cats against the deadly paralysis ticks, bush ticks, and brown dog ticks on cats.
Protection from mites - NexGard Spectra treats and controls ear mite infestations and notoedric mange and saves them from skin and ear irritations caused by them.
Protection from heart worm - Monthly treatment with NexGard Spectra prevents heart worms in cats, preventing significant heart and lung damage caused by heart worms.
Protection from lungworm - Monthly treatment with NexGard Spectra treats and controls lungworm infestations, which may cause serious and life-threatening respiratory diseases in cats.
Protection from intestinal worms - Intestinal worms can cause gastrointestinal disease, malnutrition, and anaemia in cats. NexGard Spectra is an effective worm treatment for cats that treats and controls roundworms, hookworms, and tapeworms.
